RPG Life Sciences Limited

RPGLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹781 cr, stock is ranked 1,073
Moderate RiskStock is 2.97x as volatile as Nifty
475.052.55 (+0.54%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹781 cr, stock is ranked 1,073
Moderate RiskStock is 2.97x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
15.18
PB RatioPB Ratio
3.61
Dividend YieldDiv. Yield
2.03%
Sector PESector PE
34.39
Sector PBSector PB
4.70
Sector Div YldSctr Div Yld
0.78%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

RPG Life Sciences Limited is engaged in manufacturing and marketing of pharmaceutical products. The Company operates across segments, including Domestic Formulations, International Formulations, Active Pharmaceutical Ingredients (API) and Biotech.

Investor PresentationView older 

Apr 30, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022330.96376.30390.05443.1510.8129.0140.0051.48
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnMay 11, 2022

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2022. Kindly take the same on record. | Download

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2022. Kindly take the same on record. | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 5, 2022

In continuation of our Letters dated April 25, 2022, April 29, 2022, April 30, 2022 and May 2, 2022, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2022, held on Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company¬タルs website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately. | Download

In continuation of our Letters dated April 25, 2022, April 29, 2022, April 30, 2022 and May 2, 2022, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2022, held on Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company¬タルs website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately. | Download

Cash Dividend 
Ex. DateAug 13, 2021

Final • Div/Share: ₹ 7.2

See all events